Robert Greenberg

Skechers USA Inc (NYSE: SKX) is no stranger to legal battles with its footwear competitors. Its latest dispute is with Nike Inc (NYSE: NKE), after the world’s largest sportswear company alleged Skechers ripped off two of its most popular shoe models, the VaporMax and AirMax 270. In a patent...

Skechers USA Inc (NYSE: SKX) shares traded higher after reporting a second-quarter earnings beat. Earnings came in at 49 cents per share, beating estimates by 15 cents. Sales came in at $1.26 billion, beating estimates by $40 million. The company also issued strong third-quarter earnings and sales...

Shares of this footwear maker popped after its CEO bought shares. The stock also saw an analyst's upgrade last week. The share price is still down handily year-to-date. It has been a good week for Skechers USA Inc (NYSE: SKX) investors, with the share price up around 18 percent in the wake of...

Second Sight Medical Products Inc (NASDAQ: EYES) shares are up almost 20 percent on Tuesday after the stock had an equally impressive day to start the week amid chatter its Argus II system would be included in an upcoming special on HBO's Vice. After a morning presentation at the RBC...

Second Sight Medical Products Inc (NASDAQ: EYES) shares were up sharply in early trading Tuesday after the company reported positive clinical trial results from a three-year multi center study post-implant of its Argus II Retinal Prosthesis System. The stock closed at $16.28, up 3.1 percent on...

Second Sight Medical Products Inc (NASDAQ: EYES), a U.S.-based implantable visual prosthetics company, debuted on Nasdaq on Wednesday. The stock more than doubled on its debut and recently traded at $23.31, up 16.7 percent from its Wednesday close. Robert Greenberg, president and CEO of Second...